Effects of Use of Metformin or Combination of Metformin and Pioglitazone on Oxidative Stress in Type 2 Diabetes Mellitus

  • Ayşe Tuğçenur Temiz Gençoğlu
  • Emra Asfuroglu Kalkan Ankara Bilkent City Hospital
  • Oğuzhan Zengin
  • Özcan Erel
  • İhsan Ateş
DOI: https://doi.org/10.5937/jomb0-50062
Keywords: Type 2 Diabetes Mellitus, Metformin, Pioglitazone, Oxidative Stress

Abstract


Aim: We aimed to examine how oxidative stress changes after treatment and its relationship with metabolic parameters in patients diagnosed with Type 2 Diabetes Mellitus and given metformin or metformin-pioglitazone combination.

Methods: The study population consisted of a total of 60 patients, including the group diagnosed with Type 2 Diabetes Mellitus (T2DM) and given metformin 2x1000 mg (n=30) and the group given metformin-pioglitazone 2x15/1000 mg combination (n=30). Serum IMA (ischemia modified albumin), TAS (total antioxidant status), TOS (total oxidant status) and thiol - disulphide homeostasis were measured before and after 12 weeks of treatment.

Results: No significant change was detected in Native SH and Total SH levels in both Metformin and combination groups. IMA level increased significantly in both drug groups (p=0.03, p=0.01, respectively). Although the TAS level increased in both groups, no significant change was detected. While TOS and OSI index decreased significantly in the combination group (p<0.001), the decrease was not significant in the metformin group. No significant difference was detected between Native SH, Total SH, Disulfide, IMA, TAS, TOS levels and OSI index changes of both drug groups.

Conclusion: We found that the anti-diabetic drugs used did not have a significant effect on oxidative stress.

References

[1] Matkovics B, Varga SI, Szabó L, Witas H. The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res. 1982;14(2):77-79. doi: 10.1055/s-2007-1018928. 
[2] Pitkänen OM, Martin JM, Hallman M, Akerblom HK, Sariola H, Andersson SM. Free radical activity during development of insulin-dependent diabetes mellitus in the rat. Life Sci. 1992;50(5):335-339. doi: 10.1016/0024-3205(92)90434-q.
[3] Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H,et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem. 2003;49(4):581-585. doi: 10.1373/49.4.581.
[4] Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol. 2008;49(4):260-266.
[5] Erel O, Neselioglu S. A novel and automated assay for thiol/disulphide homeostasis. Clin Biochem. 2014;47(18):326-332. doi: 10.1016/j.clinbiochem.2014.09.026.
[6] Ozler S, Oztas E, Caglar AT, Uygur D, Ergin M, Erel O et al. Thiol/disulfide homeostasis in predicting adverse perinatal outcomes at 24-28 weeks of pregnancy in gestational diabetes. J Matern Fetal Neonatal Med. 2016;29:3699–3704.
[7] Ates I, Kaplan M, Inan B, Alisik M, Erel O, Yilmaz N, et al. How does thiol/disulfide homeostasis change in prediabetic patients?. Diabetes Res Clin Pract. 2015;110:166–171.
[8] Jones DP, Liang Y. Measuring the poise of thiol/disulfide couples in vivo. Free Radic Biol Med. 2009;47(10):1329-1338. doi: 10.1016/j.freeradbiomed.2009.08.021.
[9] Piwowar A, Knapik-Kordecka M, Warwas M. Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report. Dis Markers. 2008;24(6):311-317. doi: 10.1155/2008/784313. 
[10] Chawla R, Loomba R, Guru D, Loomba V. Ischemia Modified Albumin (IMA) - A Marker of Glycaemic Control and Vascular Complications in Type 2 Diabetes Mellitus. J Clin Diagn Res. 2016;10(3):BC13-16. doi: 10.7860/JCDR/2016/15282.7432.
[11] Ghosh K, Muddeshwar MG, Ghosh K. Ischemia Modified Albumin Test to Detect Early Diabetic Complications. Am J Med Sci. 2017 Nov;354(5):467-470. doi: 10.1016/j.amjms.2017.06.017. 
[12] Ates E, Set T, Karahan SC, Biçer C, Erel Ö. Thiol/Disulphide Homeostasis, Ischemia Modified Albumin, and Ferroxidase as Oxidative Stress Markers in Women with Obesity with Insulin Resistance. J Med Biochem. 2019;38(4):445-451. doi: 10.2478/jomb-2019-0015.--14
[13] Dahiya K, Aggarwal K, Seth S, Singh V, Sharma TK. Type 2 diabetes mellitus without vascular complications and ischemia modified albumin. Clin Lab. 2010;56(5-6):187-190.
Published
2025/01/31
Issue
Ahead of print
Section
Original paper

Copyright (c) 2025 Ayşe Tuğçenur Temiz Gençoğlu, Emra Asfuroglu Kalkan, Oğuzhan Zengin, Özcan Erel, İhsan Ateş

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.